The management of cardiac arrhythmias: The role of encainide and sotalol. A symposium. March 24-25, 1988. Proceedings.
出版信息
Cardiovasc Drugs Ther. 1990 Jun;4 Suppl 3:531-634.
PMID:1980421
Abstract
摘要
相似文献
1
The management of cardiac arrhythmias: The role of encainide and sotalol. A symposium. March 24-25, 1988. Proceedings.心律失常的管理：恩卡胺和索他洛尔的作用。一次研讨会。1988年3月24日至25日。会议记录。
Cardiovasc Drugs Ther. 1990 Jun;4 Suppl 3:531-634.
2
3
A symposium: Encainide. January 24-25, 1986, Phoenix, Arizona.一场研讨会：恩卡尼。1986年1月24日至25日，亚利桑那州凤凰城。
Am J Cardiol. 1986 Aug 29;58(5):1C-116C.
4
Clinical pharmacology of antiarrhythmic agents.
Cardiovasc Clin. 1985;16(1):287-305.
5
Encainide for cardiac arrhythmias.恩卡尼用于治疗心律失常。
Med Lett Drugs Ther. 1987 May 22;29(740):50-2.
6
Efficacy of encainide in supraventricular arrhythmias.
Cardiovasc Drugs Ther. 1990 Jun;4 Suppl 3:573-7. doi: 10.1007/BF00357033.
7
8
Comparison of the effects of placebo and encainide on programmed electrical stimulation and ventricular arrhythmia frequency.
Am J Cardiol. 1982 Aug;50(2):305-12. doi: 10.1016/0002-9149(82)90181-3.
9
10
Ventricular arrhythmias: risk stratification and approach to therapy after the Cardiac Arrhythmia Suppression Trial (CAST).室性心律失常：心律失常抑制试验（CAST）后的风险分层及治疗方法
Pacing Clin Electrophysiol. 1990 Nov;13(11 Pt 2):1480-7. doi: 10.1111/j.1540-8159.1990.tb04028.x.
Zotero 插件